RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,774,916 | +140.1% | 10,689,532 | +134.4% | 0.01% | +133.3% |
| Q2 2023 | $34,060,188 | -46.3% | 4,559,597 | -52.1% | 0.00% | 0.0% |
| Q1 2023 | $63,437,846 | +84.2% | 9,510,922 | +113.0% | 0.00% | 0.0% |
| Q4 2022 | $34,430,661 | -23.9% | 4,465,715 | +5.0% | 0.00% | -40.0% |
| Q3 2022 | $45,233,000 | +95.9% | 4,251,164 | +49.9% | 0.01% | +150.0% |
| Q2 2022 | $23,084,000 | +50.3% | 2,835,852 | +32.2% | 0.00% | +100.0% |
| Q1 2022 | $15,363,000 | -41.4% | 2,145,639 | +40.2% | 0.00% | -50.0% |
| Q4 2021 | $26,213,000 | -41.9% | 1,530,226 | -21.9% | 0.00% | -50.0% |
| Q3 2021 | $45,099,000 | -44.1% | 1,959,963 | -11.4% | 0.00% | -33.3% |
| Q2 2021 | $80,724,000 | – | 2,211,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |